Contributor

Kristin Houser

Staff Writer

Contact

[email protected]

Kristin Houser is a staff writer at Freethink, where she covers science and tech. Her written work has appeared in Business Insider, NBC News, and the World Economic Forum’s Agenda, among other publications, and Stephen Colbert once talked about a piece on The Late Show, to her delight.

Prior to joining Freethink, Kristin was a staff writer for Futurism and wrote several animated and live action web series.

Archaeology

Lasers reveal hundreds of Mayan and Olmec ceremonial centers

Archaeologists are hunting for — and finding — previously hidden ancient structures in lidar data collected by planes and drones.

Kristin Houser

Surgery

Tissue implant extends lives of children born with athymia

A treatment that could dramatically extend the lives of children born with the rare condition athymia has been approved by the FDA.

Kristin Houser

3D Printing

ICON to build world’s largest community of 3D-printed houses

Startup ICON is building the world’s largest community of 3D-printed houses — a move that could help bring the homes to the mainstream.

Kristin Houser

Cars

Autonomous race cars compete for $1 million prize

Autonomous race cars sped around a world-famous track in pursuit of a $1 million prize during the Indy Autonomous Challenge.

Kristin Houser

Aerospace

New thruster tech that vaporizes metal could help clean up space

Hypernova Space Technologies’ metal-fueled propulsion system for small satellites could be a game-changer for space exploration.

Kristin Houser

Homelessness

Nonprofit builds tiny houses for homeless people in backyards

Facing Homelessness builds tiny houses for homeless people in Seattle homeowners' backyards to address a shortage of affordable housing.

Kristin Houser

Transportation

You can now buy a flying car for $92,000

More than 150 companies are developing flying cars. Here's why they're aren't yet off the ground and darting across city skies.

Kristin Houser

Medicine

Preventative breast cancer vaccine enters human trials

A breast cancer vaccine entering human trials is designed to prevent triple-negative breast cancer — the deadliest, most aggressive form.

Kristin Houser

Coronavirus

Merck is making its COVID-19 antiviral pill more affordable to low-income countries

Drug maker Merck has agreed to license a promising antiviral pill to treat COVID-19 to low- and middle-income countries for free.

Kristin Houser

Coronavirus

You can now mix and match COVID-19 booster shots

Americans eligible for COVID-19 booster shots no longer need to stick to one brand. Here’s why that’s a big deal.

Kristin Houser